发布时间：2008.6
摘要
The Freedonia Group Incorporated is a leading international industry study/database company. Founded in 1985, Freedonia now publishes over 100 studies each year, covering such areas as building materials, chemicals,health care, packaging, pharmaceuticals, plastics, security and many otherindustries. Studies cover entire industry sectors as well as key nichemarkets. Each study includes such valuable intelligence as growth marketsand products, market share, product analyses and forecasts, market analysesand forecasts, and company profiles.This comprehensive study analyzes the US market for enzymes, both specialty and industrial. The term "enzymes" includes specialty andindustrial enzymes typically manufactured using fermentativemicroorganisms, as well as enzymes sourced from plants and animals. Specific types of enzymes examined include carbohydrases, proteases,polymerases, nucleases, lipases and others. Carbohydrases covered include recombinant human glycosidases (rHglycosidases), alpha amylases, glucoamylases, glucose isomerases, cellulases and pectinases, among others. Cellulases, as covered in this study, include all enzymes acting on cellulosic fiber-type materials, which encompass both cellulases and hemicellulases. Major enzyme market sectors covered in the study include pharmaceuticals, starch processing, research and biotechnology, food and beverage processing, cleaning products, diagnostics and animal feed. Additionally,several smaller markets are also covered, including biocatalysts, cosmetics and toiletries, textiles and leather, pulp and paper, and others. Dietary supplement/nutraceutical enzyme demand is included in the digestive pharmaceutical market. Beverage ethanol enzyme demand is included within the food and beverage market and not the starch processing market. Pharmaceutical enzyme demand projections are based upon existing drugs and developmental compounds presently in clinical trials. Historical data for 1997, 2002 and 2007 and forecasts to 2012 and 2017 are provided. Unless otherwise indicated, all figures represent demand for enzymes stated in current US dollars. The term "demand" refers to US demand, sales or apparent consumption and denotes US production plus
imports less exports. Demand is presented at the manufacturers' level. Demand data may also include captive production and use. Tabular details may not add to totals due to independent rounding and ratios may be rounded for the sake of clarity. Information and data on the US enzyme market were obtained from a variety of primary and secondary sources, including government and trade associations, industry participants, online databases and other Freedonia studies. Primary information was gathered through consultations with personnel of participating companies. Secondary and background data were obtained from various government and trade publications including Chemical & Engineering News, Chemical Week, Drug Topics, Feedstuffs, Genetic Engineering News, ICIS Chemical Business, Med Ad News and R&D Directions. Corporate annual reports, SEC Form 10-K filings, product literature and other company information were also used in framing the industry and market environments and as input for market size assessments. Macroeconomic and demographic indicators used in this study were obtained
from The Freedonia Group Incorporated consensus forecasts dated April 2008.
目录及图表
SECTION PAGE
INTRODUCTION x
I. EXECUTIVE SUMMARY 1
II. MARKET ENVIRONMENT 4
General 4
Demographic Trends 5
Macroeconomic Outlook 8
Consumer Spending 13
Manufacturing Trends 15
Food & Beverage Industry Outlook 18
Agricultural Outlook 21
Crop Production 25
Livestock & Poultry 26
National Health Expenditures 28
Petroleum & Refining Industry Overview 31
Historical Market Trends 35
Pricing & Product Mix 38
Environmental & Regulatory Considerations 40
Intellectual Property Considerations 42
International Activity 44
Foreign Trade & US Production 45
Exports 47
Imports 48
III. TECHNOLOGY 51
General 51
Enzyme Production Overview 52
Recombinant DNA Technology 54
Directed Evolution & Gene Shuffling 55
Protein Engineering Technology 57
Molecular Screening & Bioinformatics 57
Enzyme Immobilization 58
Extremeophilic Enzymes 60
Enzyme Factories 61
IV. MARKETS 63
General 63
Pharmaceuticals 65
Pharmaceutical Industry Overview 66
Enzyme Demand 67
Enzyme Replacement Therapy 70
Neuromodulator 74
Digestive 78
Cardiovascular Thrombolytic 83
Other Pharmaceutical 86
Starch Processing 91
Ethanol 92
Industry Outlook 93
Enzyme Demand 95
Sweeteners 101
Industry Outlook 101
Enzyme Demand 102
Research & Biotechnology 105
Research & Biotechnology Industry Outlook 106
Enzyme Demand 108
DNA Amplification & Sequencing 110
Other Research Enzyme Markets 113
Food & Beverage Processing 115
Dairy Products 118
Industry Outlook 118
Enzyme Demand 120
Bakery Products 126
Industry Outlook 126
Enzyme Demand 128
Beverage Processing 132
Industry Outlook 132
Enzyme Demand 135
Other Food & Beverage Applications 140
Cleaning Products 143
Cleaning Product Industry Outlook 144
Enzyme Demand 146
Laundry Detergents 148
Dishwashing Detergents & Other Cleaners 151
Diagnostics 153
Diagnostic Industry Outlook 154
Enzyme Demand 156
Animal Feed 159
Animal Feed Industry Outlook 160
Enzyme Demand 163
Other Enzyme Markets 169
Biocatalysts 170
Cosmetics & Toiletries 174
Textile & Leather 177
Pulp & Paper 184
All Other 187
V. PRODUCTS 190
General 190
Carbohydrases 193
Alpha Amylases 196
Glucoamylases 200
Recombinant Human Glycosidases 201
Cellulases 203
Glucose Isomerases 206
Lactases 208
Pectinases 209
Other Carbohydrases 212
Proteases 214
Microbial Proteases 216
Fibrinolytic Proteases 219
Rennet/Chymosin 222
Other Proteases 223
Polymerases 225
Nucleases 227
DNases 229
Other Nucleases 230
Lipases 233
Other Enzymes 236
I. INDUSTRY STRUCTURE 241
General 241
Market Share 246
Competitive Strategies 249
Research & Development 251
Cooperative Agreements 252
Acquisitions & Divestitures 256
Manufacturing 259
Marketing & Distribution 260
Company Profiles 262
AB Enzymes, see Associated British Foods
Advanced Enzyme Technologies Limited 263
Agilent Technologies Incorporated 266
Allergan Incorporated 267
Amano Enzyme Incorporated 269
Applera Corporation 271
Applied Biosystems, see Applera Corporation
Associated British Foods plc 273
Axcan Pharma Incorporated 276
BASF SE 278
Biomethodes 281
Biozyme Laboratories, see Inverness Medical Innovations
Cargill Incorporated 282
Chr. Hansen A/S 284
Codexis Incorporated 286
CSL Limited 290
Danisco A/S 291
DFB Pharmaceuticals Incorporated 296
Dyadic International Incorporated 298
EKR Therapeutics Incorporated 300
Frutarom Limited 301
Genentech Incorporated 302
Genzyme Corporation 304
Healthpoint, see DFB Pharmaceuticals
ImaRx Therapeutics Incorporated 306
Inverness Medical Innovations Incorporated 308
Invitrogen Corporation 309
Iogen Corporation 311
Ipsen 313
LIST OF CHARTS
CHART NUMBER PAGE
SECTION II -- MARKET ENVIRONMENT
1 Enzyme Market, 1997 - 2007 38
2 Enzyme Exports by Country, 2007 48
3 Enzyme Imports by Country, 2007 50
SECTION IV -- MARKETS
1 Enzyme Demand by Market, 2007 65
SECTION V -- PRODUCTS
1 Enzyme Demand by Product, 2007 193
SECTION VI -- INDUSTRY STRUCTURE
1 Enzyme Market Share, 2007 246